Mar 16, 2022
The participant was born full-term after a pregnancy that was normal except for well-controlled gestational diabetes. His head was smaller than expected (fetal microcephaly) beginning at 30 weeks gestation. At birth, he was noted to be small in size and have corneal clouding, small corneas (microcornea), small eyes (microphthalmia), and a small penis (micropenis). His eye findings normalized over time but he continued to have visual impairment due to nearsightedness (high myopia) and damage in the brain (cerebral visual impairment). The newborn screening hearing test was abnormal and follow-up testing confirmed hearing loss (sensorineural hearing loss).
At about 3 months, the participant was diagnosed with Graves’ disease (autoimmune hyperthyroidism) and had his thyroid removed at 9 months. Liver function tests showed elevated enzyme levels that were suspicious for liver damage or inflammation. Follow-up tests did not provide a more specific diagnosis. The participant also had difficulties feeding that required a G-tube.
The participant was found to have global developmental delay, muscle weakness closer to the torso (proximal weakness), low muscle tone (hypotonia), and increased muscle tone (hypertonia) at different areas in the body. He did not have seizures, but an EEG was abnormal, indicating disease in the brain (mild generalized encephalopathy). Brain MRIs did confirm multiple structural brain abnormalities and calcium buildup (calcifications).
The participant was diagnosed with heart disease (left ventricular hypertrophy), mild enlargement of the aorta (aortic dilation), and backward flow of blood through some valves in the heart (moderate aortic, mitral, and bicuspid valve regurgitation). His left ventricular hypertrophy and valvular regurgitation improved after his thyroidectomy but did not go away.
At approximately 15 months, the participant began experiencing episodes in which his breathing stopped (central apnea) and his heart rate slowed (bradycardia). These episodes worsened over time, and the participant passed away at 19 months. An autopsy confirmed the findings that were seen in life and noted some additional findings, including a rare cardiac disorder (histiocytoid cardiomyopathy), abnormal blood vessels between the heart and lungs (pulmonary vasculature), and inflammation of the brain (encephalitis).
Exome sequencing revealed that part of the participant’s DNA was duplicated in an area that included the genes ATAD3A, ATAD3B, and ATAD3C. It is now believed that this genetic change was the cause of his condition.
Clinicians and researchers have identified the following de novo duplication, involving all of ATAD3B and part of ATAD3A and ATAD3C, to be causing the participant’s symptoms. The variant is thought to be the result of a complex chromosomal rearrangement, and further investigation is underway.
If this participant sounds like you or someone you know, please contact us!
The information provided here is based on individual patient experiences. This information is not meant to substitute for advice of a qualified health care provider. Please do not use this information to diagnose or develop a treatment plan for a health problem or disease without consulting a qualified health care provider.
Any mention of products or services is not meant as a recommendation of the products or services. Please discuss any options with a qualified health care provider.
Developments in medical research may impact the information that appears here. No assurance can be given that the information in this site will include the most recent findings or developments.
The use of any information provided on this site is solely at your own risk.